Publication | Closed Access

A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I

Histone DeacetylaseOncologyDual InhibitionMedicineDaca DisplaysAnti-cancer AgentCancer TreatmentProstatic DiseasePharmacologyRadiation OncologyEndocrine-related CancerDrug Discovery